Given the established association between GRN mutations and TDP pathology, the decrease of GRN (progranulin) protein levels observed in FTLD-TDP aligns with previous GRN reductions in CSF and plasma of FTD-GRN mutation carriers [84, 85]. This evidence concerns the gene GRN and frontotemporal dementia.